Correspondence

ACMD advice on reform to hemp licensing fees

The Advisory Council on the Misuse of Drugs responds to the government on their proposal to amend the licensing regimen for industrial hemp.

• From: Advisory Council on the Misuse of Drugs
• Published: 23 October 2024

Documents

ACMD advice on reform to hemp licensing fee (accessible)

HTML

ACMD advice on reform to hemp licensing fee

PDF, 207 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

On 9 April 2024 the Advisory Council on the Misuse of Drugs (ACMD) was commissioned to provide advice on a proposal to amend the licensing regimen for industrial hemp.

The ACMD is supportive of the proposed change to increase the maximum THC content of industrial hemp grown outdoors for seed production or in order to use the non-controlled parts of the plant to produce fibre for use in the construction and textile industries from 0.2% to 0.3%, as the potential benefits outweigh an increased risk of harms.

The ACMD recommends the Home Office to conduct an assessment of the impact of the legislative change after 2 years. The ACMD foresees no issues with applying the lower fee of £580 to a raised level of THC not exceeding 0.3%, to align with other international examples.

Published 23 October 2024